Towards Healthcare
Genomics Life Science Analytics Market 2025 Surges in Software and Cloud Adopt...

Genomics Life Science Analytics Market North America Holds 50% Share in 2025

The growing demand for personalized medicine and drug discovery development approaches is driving the global market growth. North America dominated the market due to increasing research activities in genomics and analytics, with technological advancements.

  • Insight Code: 5807
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

North America is currently leading the genomics life science analytics market due to rising research activities regarding genomics and increasing focus on technological advancements.

The genomics life science analytics market includes six segments, such as by product type, by application, by technology, by deployment mode, by end use, and by region, etc.

Some key players include Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., BGI Genomics Co., Ltd., and Agilent Technologies, Inc.

Key trends include rising demand for drug discovery and personalized medicine, growth in advanced tools, and innovation in clinical trials, novel molecules.

The key technologies and tools used in genomic data analysis are bioinformatics pipelines, statistical analysis software, machine learning and AI, and cloud computing platforms.

Life science analytics comprises the application of data analysis, machine learning, and other computational techniques to examine data generated within the life sciences domain.

NIH.GOV, US FDA.GOV, PIB.GOV, GOV.UK, CDC.GOV, NHS.GOV, OGD, NDAP.GOV, NIC.GOV